EUVIMEDEUVIMED entdecken
Crossref

Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1

Gyeol Seong, Joo Hye Song, Ji Eun Kim, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Seok-Hyung Kim, Sang Yun Ha, Young-Ho Kim iD

Inflammatory Bowel Diseases · 2023

DOI: 10.1093/ibd/izac075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2023. Verfasst von Gyeol Seong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Nowon Eulji Medical Center, Eulji University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Science, ICT & Future Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The treatment goal of ulcerative colitis (UC) has changed from the control of symptoms to mucosal healing, previously evaluated mainly by endoscopy. Recently, the importance of histologic activity has emerged. Therefore, this study aimed to investigate the risk of clinical relapse according to histologic activity in UC with a Mayo endoscopic subsccore (MES) of 0 or 1.

Methods

In a retrospective cohort after our center’s biopsy guideline for UC was instituted, 492 UC patients with an MES of 0 or 1 were enrolled and analyzed. The primary outcome was the development of a clinical relapse including changes in medication, hospitalization, colectomy, and the development of colorectal cancer during the follow-up period.

Results

During the median 549 days of follow-up, 92 (18.7%) patients had a clinical relapse. All the patients changed their medication, including 4 hospitalized patients. Histologic activity defined by a Geboes score of ≧3.1 (hazard ratio [HR], 1.732; P = .035) and steroid use history (HR, 1.762; P = .008) were independent factors associated with clinical relapse. When stratified, the 1- and 2-year incidence rates of clinical relapse were 4.1% and 10.6%, respectively, for patients with histologic improvement and no steroid use history, whereas the rates were 23.9% and 39.4% for patients with histologic activity and steroid use history.

Conclusions

In UC with an MES of 0 or 1, histologic activity and steroid use history can be used to stratify the risk of clinical relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeHumansRetrospective StudiesColonoscopyIntestinal MucosaRisk FactorsChronic DiseaseRecurrenceSeverity of Illness Index

Stichwörter der Autor:innen

endoscopic healinghistologic activitymucosal healingulcerative colitis

Autor:innen und Institutionen

  • Department of Medicine, Nowon Eulji Medical Center, Eulji University College of Medicine, Seoul, Korea.
  • Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ORCID-Profile: Young-Ho Kim

Förderung

  • National Research Foundation of Korea
  • Ministry of Science, ICT & Future Planning

Zitieren

APA

Seong, G., Song, J. H., Kim, J. E., Kim, T. J., Kim, E. R., Hong, S. N., Chang, D. K., Kim, S. H., Ha, S. Y., & Kim, Y. H. (2023). Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izac075

Vancouver

Seong G, Song JH, Kim JE, Kim TJ, Kim ER, Hong SN, et al. Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1. Inflammatory Bowel Diseases. 2023. doi:10.1093/ibd/izac075

BibTeX
@article{Seong2023,
  author = {Seong, Gyeol and Song, Joo Hye and Kim, Ji Eun and Kim, Tae Jun and Kim, Eun Ran and Hong, Sung Noh and Chang, Dong Kyung and Kim, Seok-Hyung and Ha, Sang Yun and Kim, Young-Ho},
  title = {Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1},
  journal = {Inflammatory Bowel Diseases},
  year = {2023},
  doi = {10.1093/ibd/izac075}
}
Kostenlos starten →